UPDATE 4-Biosimilar worries takes shine off Roche's guidance hike
April 26, 2018 at 06:33 AM EDT
* Sales of cancer drug Rituxan drop on biosimilar challenge (Adds analyst comment, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||